Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carbon Biosciences
Lexington, Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Carbon Biosciences is developing a novel parvovirus-based gene therapy platform. Its lead candidate CGT‑001 targets cystic fibrosis with demonstrated upper airway tropism and repeatable dosing in preclinical models. The company has raised $38M Series A funding to advance its pipeline toward the clinic. No human clinical results have been reported yet.
- Therapeutic areas
- Rare DiseasesPulmonologyCardiovascular
- Modalities
- Gene therapyViral vector-based gene therapy (specifically parvovirus-derived vectors)Potential for multiple modalities via proprietary platform ("PAVE")
- Industry
- Biotech
02
Partnerships
Cystic Fibrosis Foundation ($6M investment/collaboration)Longwood Fund founding partner/investoracademic collaborations with University of Iowa and UMass Chan Medical School through scientific co-founders John F. Engelhardt and Robert M. Kotin
Beyond the preview
Go deeper on Carbon Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Carbon Biosciences.